EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cost-effectiveness of preoperative parathyroid imaging in primary hyperparathyroidism: A synthesis of eight health-economic analyses

Petra Petranović Ovčariček, Matija Romić, Vedrana Gladić Nenadić, Martin W Huellner

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8005-8013

DOI: 10.1007/s00259-026-08123-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 07.08.2026. Verfasst von Petra Petranović Ovčariček und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, 10 000, Croatia. p.petranovic@gmail.com. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Cost-Effectiveness Analysis, Cost-Benefit Analysis, Preoperative Care. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Preoperative localisation of hyperfunctioning parathyroid tissue underpins minimally invasive parathyroidectomy (MIP) in primary hyperparathyroidism (pHPT). Cervical ultrasound (cUS), [⁹⁹ᵐTc]Tc-sestamibi ([⁹⁹ᵐTc]Tc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT), and choline positron emission tomography/computed tomography (PET/CT) differ in diagnostic accuracy and cost. Whether choline PET/CT should be reserved for second-line use or implemented first-line remains debated. We synthesised cost-effectiveness evidence from recent health-economic analyses across different healthcare systems.

Methods

In this narrative review, MEDLINE (via PubMed) was searched for original health-economic analyses evaluating preoperative parathyroid imaging in pHPT published 2022–2026, supplemented by reference-list screening. Eight studies were included. The modelling framework, analytical perspective, imaging comparators, base-case costs, incremental cost-effectiveness ratios (ICERs), incremental cost-utility ratios (ICURs) and willingness-to-pay (WTP) thresholds were extracted.

Results

The included studies comprised two retrospective cohorts, three decision trees, one Markov model, one cohort-level state-transition model, and one randomised controlled trial (APACH2). Across most healthcare settings, first-line choline PET/CT was more cost-effective than [⁹⁹ᵐTc]Tc-MIBI-based pathways. Reported ICERs included €471 per additional surgical cure (APACH2), US$470 per quality-adjusted life-year (QALY) (USA), €12,650 per QALY (France), and Colombian pesos (COP) 101,727–277,037 per additional cure. At one Dutch centre, [¹¹C]choline PET/CT was a dominant strategy (ICUR −€18,846/QALY), while a Spanish cohort demonstrated approximately 19% lower per-patient costs with PET-only imaging. PET tariff and local [⁹⁹ᵐTc]Tc-MIBI performance were the principal determinants of cost-effectiveness.

Conclusions

First-line choline PET/CT is cost-effective compared with [⁹⁹ᵐTc]Tc-MIBI-based imaging pathways across most WTP thresholds. Implementation should be guided by local PET reimbursement and [⁹⁹ᵐTc]Tc-MIBI performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryCost-Effectiveness AnalysisCost-Benefit AnalysisPreoperative CareParathyroid GlandsHumansPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

Cost-effectivenessMinimally invasive parathyroidectomyParathyroid imagingPrimary hyperparathyroidism[¹⁸F]fluorocholine PET/CT[⁹⁹ᵐTc]Tc-MIBI SPECT/CT

Autor:innen und Institutionen

  • Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, 10 000, Croatia. p.petranovic@gmail.com.
  • School of Medicine, University of Zagreb, Zagreb, Croatia. p.petranovic@gmail.com.
  • Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, 10 000, Croatia.
  • Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland.
  • Department of Nuclear Medicine, University of Zurich, Zurich, Switzerland.

Zitieren

APA

Petranović Ovčariček, P., Romić, M., Gladić Nenadić, V., & Huellner, M. W. (2026). Cost-effectiveness of preoperative parathyroid imaging in primary hyperparathyroidism: A synthesis of eight health-economic analyses. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8005-8013. https://doi.org/10.1007/s00259-026-08123-7

Vancouver

Petranović Ovčariček P, Romić M, Gladić Nenadić V, Huellner MW. Cost-effectiveness of preoperative parathyroid imaging in primary hyperparathyroidism: A synthesis of eight health-economic analyses. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8005-8013. doi:10.1007/s00259-026-08123-7

BibTeX
@article{PetranoviOvariek2026,
  author = {Petranović Ovčariček, Petra and Romić, Matija and Gladić Nenadić, Vedrana and Huellner, Martin W},
  title = {Cost-effectiveness of preoperative parathyroid imaging in primary hyperparathyroidism: A synthesis of eight health-economic analyses},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {8005--8013},
  doi = {10.1007/s00259-026-08123-7}
}
Kostenlos starten →